Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosducin-like protein is a cytoplasmic protein encoded by the PDCL gene in humans. It shares significant sequence homology with phosducin, a phosphoprotein in the retina and pineal gland. Phosducin-like protein regulates G-protein signaling by binding to the beta-gamma subunits of heterotrimeric G proteins, modulating their interaction with alpha subunits, effectors, and membranes. It acts as a co-chaperone for the CCT complex, facilitating assembly of G protein complexes such as Gbeta-Ggamma and RGS-Gbeta5 heterodimers. The protein also participates in ciliary function and is implicated as a positive regulator of hedgehog signaling. Disease associations are limited, with minor links to certain allergic conditions, and there are no known direct drug interactions or established roles as a biomarker or therapeutic target[1][2][3][5][6]. **Key points:** Phosducin-like protein (PDCL) is not currently considered a major therapeutic target, receptor, or enzyme. Its main function is modulation of G protein assembly and signaling, but it lacks established roles in widely targeted clinical pathways or pharmacological interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosducin-like protein (PDCL).